Advanced precision modeling reveals divergent responses of hepatocellular carcinoma to combinatorial immunotherapy
Jinping Liu1, Lan Cheng2, Hilana El-Mekkoussi1
1Department of Genetics and Center for Molecular Studies in Digestive and Liver Disease, University of Pennsylvania, Philadelphia, PA, USA.
Cancer Communications (London, England)
|April 10, 2023
Abstract
No abstract available in PubMed .
Related Concept Videos
01:27Tumor Immunotherapy
597
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
597
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K